Profile: Stryker Corp (SYK)
16 Mar 2018
Stryker Corporation (Stryker), incorporated on February 20, 1946, is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company's segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The Company's MedSurg segment consists of instruments, endoscopy, medical and sustainability products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products.
The Company's products include implants, which are used in joint replacement and trauma surgeries, and other products that are used in a range of medical specialties. The Company's MedSurg segment products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. Its Neurotechnology and Spine segment products consist of both neurosurgical and neurovascular devices. The Company's neurotechnology offering includes products used for minimally invasive endovascular techniques; a line of products for traditional brain and open skull based surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke.
The Company's spinal implant offering includes cervical, thoracolumbar and interbody systems that are used in spinal injury, deformity and degenerative therapies. The Company's products are marketed directly to doctors, hospitals and other healthcare facilities in the United States. As of December 31, 2016, its products were sold in over 100 countries through Company-owned sales subsidiaries and branches, as well as third-party dealers and distributors.
The Company competes with Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Johnson & Johnson, CONMED Corporation, Medtronic plc., Terumo Corporation, Penumbra, Inc., Arthrex, Inc., Karl Storz GmbH & Co., Olympus Optical Co. Ltd., STERIS plc, Hill-Rom Holdings, Inc., Zoll Medical Corporation, Koninklijke Philips N.V., Nuvasive, Inc. and Globus Medical, Inc.
2825 Airview Blvd
PORTAGE MI 49002-1802
Company Web Links
- BRIEF-Stryker's Spine Division Receives FDA Clearance For 3D-Printed Tritanium Tl Curved Posterior Lumbar Cage
- BRIEF-Reg-Stryker Corp Announces Pricing Of $600 Million Senior Notes Offering
- BRIEF-Stryker Says Holds 95 Pct In Vexim; Intends To File Public Buy-Out Offer
- BRIEF-Stryker Crosses 95 Pct Thresholds In Vexim
- BRIEF-Stryker Declares $0.47 Per Share Quarterly Dividend